TriangleGAVEL (NCT07439211)
GAVEL trial for Acute Myeloid Leukemia (NCT07439211). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for adults with acute myeloid leukemia.
The idea: add eganelisib, a capsule that blocks PI3K gamma, to a standard treatment of venetoclax, a pill, and azacitidine, given as a shot or by vein.
The study looks at safety and early signs that adding eganelisib helps.
This phase 1 study plans 48 patients. At Dana-Farber Cancer Institute in Boston, Jacqueline Garcia leads it.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.